News | Artificial Intelligence | March 08, 2018

Nuance and Partners HealthCare Collaborate to Create AI Marketplace for Diagnostic Imaging

Collaboration focused on optimizing the development, clinical validation and usability of practical artificial intelligence applications

March 8, 2018 — Nuance Communications Inc. announced the signing of a multi-year strategic agreement with Partners HealthCare at the 2018 Healthcare Information and Management Systems Society annual meeting (HIMSS18), March 5-9 in Las Vegas. The two organizations will optimize the process for rapid development, validation and utilization of artificial intelligence (AI) for radiologists at the point of care, and Nuance intends to make the new algorithms available through the Nuance AI Marketplace for Diagnostic Imaging. The collaboration will be executed through the recently formed Massachusetts General Hospital (MGH) and Brigham and Women’s Hospital (BWH) Center for Clinical Data Science (CCDS) and will focus on improving radiologists’ efficiency and report quality, as well as patient clinical outcomes.

Nuance and Partners Healthcare will work together, and with other key supporters of the Nuance AI Marketplace for Diagnostic Imaging including NVIDIA and the American College of Radiology. The collective will continue to foster the democratization of imaging AI, with an emphasis on automating many of the mundane and repetitive tasks radiologists face daily. The AI Marketplace is an open platform for developers, data scientists and radiologists to accelerate the development, deployment and adoption of AI for medical imaging. The Marketplace will leverage the large number of radiologists in the U.S. already using Nuance’s PowerScribe radiology reporting and PowerShare image exchange network. Specifically, technology partners can now seamlessly deploy their algorithms into Nuance’s cloud-based PowerShare Network and users can easily select them through the PowerScribe radiology reporting platform. This enables the algorithms to be accessed within a radiologist’s native workflow, eliminating the need to buy new reporting or image sharing systems.

Accessibility and efficiency are major drivers of the work taking place at the CCDS. "We spend a lot of energy thinking about how to develop and effectively deliver tools into the clinical workflow — starting upstream with designing smarter imaging modalities to downstream automation of reporting workflows" said Mark Michalski, M.D., executive director of the CCDS. "As AI toolsets are increasingly democratized, scaling the delivery and integration of these tools is likely to represent a barrier to broad adoption." Through investment in the CCDS, MGH and BWH leadership is actively building the technical capabilities and industry relationships needed to lower these barriers and help bring solutions to market.

“For AI algorithms to be useful to radiologists and patients, it is critical that they are both clinically validated and accessible through the existing reporting workflow,” said Keith Dreyer, DO, Ph.D., FACR, FSIIM, chief data science officer, Partners HealthCare. “Through this collaboration with Nuance, radiologists will be able to access and leverage validated AI and deep learning algorithms without leaving their preferred workflow. Partnerships like this are a game changer given the time savings, increases in productivity and improved quality outcomes enabled for radiology staff.”

Nuance also released a whitepaper on the AI Marketplace, “AI Access for All: The power and promise of AI for radiology," that is available for download.

For more information: www.nuance.com

 

Related Content

The interior of the German air force Airbus A-310 Medivac in Cologne, Germany, before its departure to Bergamo, Italy, March 28 to being ferrying COVID-19 patients to Germany for treatment to aid the Italians, whose healthcare system has been overwhelmed by the rapid spread of the coronavirus pandemic. Bundeswehr Photo by Kevin Schrief.

The interior of the German air force Airbus A-310 Medivac in Cologne, Germany, before its departure to Bergamo, Italy, March 28 to being ferrying COVID-19 patients to Germany for treatment to aid the Italians, whose healthcare system has been overwhelmed by the rapid spread of the coronavirus pandemic. Bundeswehr Photo by Kevin Schrief. Find more images from the COVID-19 pandemic.

 

Feature | Coronavirus (COVID-19) | April 08, 2020 | By Melinda Taschetta-Millane and Dave Fornell
In an effort to keep the imaging field updated on the latest information being released on coronavirus (COVID-19), th
A recent study earlier this year in the journal Nature, which included researchers from Google Health London, demonstrated that artificial intelligence (AI) technology outperformed radiologists in diagnosing breast cancer on mammograms
Feature | Breast Imaging | April 06, 2020 | By Samir Parikh
A recent study earlier this year in the journal Nature,
Varian received FDA clearance for its Ethos therapy in February 2020. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Varian received FDA clearance for its Ethos therapy in February 2020, shown here displayed for the first time at ASTRO 2019. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Feature | Treatment Planning | April 03, 2020 | Dave Fornell, Editor
The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new
An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal.

An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. Photo by Dave Fornell

Feature | Radiology Imaging | April 02, 2020 | By Katie Caron
A new year — and decade — offers the opportunity to reflect on the advancements and challenges of years gone by and p
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus

Getty Images

Feature | Coronavirus (COVID-19) | April 02, 2020 | Jilan Liu and HIMSS Greater China Team
Information technologies have played a pivotal role in China’s response to the novel coronavirus...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 the company is now offering a suite of AI solutions Vuno Med-LungQuant and Vuno Med-Chest X-ray for COVID-19, encompassing both lung X-ray and computed tomography (CT) modalities respectively all at once
News | Artificial Intelligence | April 02, 2020
April 2, 2020 — In the face of the COVID-19 pand
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 The Chinese start-up company Infervision launches its AI-based solution InferRead CT Lung Covid-19 also in Europe
News | Artificial Intelligence | March 31, 2020
March 31, 2020 — Lung infections generated by the coronavirus can be detected in...